Clinical features of hepatitis B virus-related hepatocellular carcinoma

被引：33
|
作者：
Ishikawa, Toru [1 ]
机构：
[1] Saiseikai Niigata Second Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2010年 / 16卷 / 20期
关键词：
Hepatocellular carcinoma; Hepatitis B virus; LIVER RESECTION; INTERFERON; RECURRENCE; LAMIVUDINE; CIRRHOSIS; SURVIVAL; INFECTION; THERAPY; INTEGRATION; ABLATION;
D O I：
10.3748/wjg.v16.i20.2463
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatocellular carcinoma (HCC) is a major cause of cancer death, and chronic hepatitis B is a serious worldwide problem. The epidemiology of HCC is distinctive. Hepatitis B virus (HBV) plays a major role in hepatocarcinogenesis. Prevention of HBV-related HCC is a key issue in current hepatology. This paper describes the prevention and clinical features of HBV-related HCC, along with a short review of the disease. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码：2463 / 2467
页数：5
相关论文
共 50 条
  • [41] Expression of metastatic tumor antigen 1 correlates with tumor and clinical features of patients with hepatitis B virus-related hepatocellular carcinoma
    Liu, C-J
    Li, Y-T
    Kao, J-H
    Chen, D-S
    Chen, P-J
    Wu, H-L
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 50 - 50
  • [42] Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma
    Zhu, Qianqian
    Li, Fang
    Sang, Jiao
    Deng, Huan
    Han, Qunying
    Lv, Yi
    Li, Chunyan
    Liu, Zhengwen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 49 : 126 - 131
  • [43] Prevention of hepatitis C virus-related hepatocellular carcinoma
    Heathcote, EJ
    GASTROENTEROLOGY, 2004, 127 (05) : S294 - S302
  • [44] Clinical significance of antibody against hepatitis B virus core antigen in patients with hepatitis C virus-related hepatocellular carcinoma
    Yano, Y
    Yamashita, F
    Sumie, S
    Kuwaki, K
    Yamamoto, H
    Toyoda, N
    Ando, E
    Tanaka, M
    Sata, M
    LIVER INTERNATIONAL, 2003, 23 (04): : 227 - 231
  • [45] Expression of MicroRNA-155 in Hepatitis B Virus-Related to Hepatocellular Carcinoma
    Renovaldi, Dede
    Radityaningsih, Juwita
    Lestari, Puji
    Qoriansas, Nanda
    Heriyanto, Didik Setyo
    Ratnasari, Neneng
    Haryana, Sofia Mubarika
    PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON SUSTAINABLE INNOVATION 2020 - HEALTH SCIENCE AND NURSING (ICOSIHSN 2020), 2021, 33 : 12 - 16
  • [46] Imaging advances in diagnosing and grading hepatitis B virus-related hepatocellular carcinoma
    Jiachen Liu
    Hongjun Li
    Infection Control, 2024, 1 (04) : 13 - 22
  • [47] Hepatocellular carcinoma and lymphoma - two hepatitis B virus-related malignant diseases?
    Yeo, W
    Hui, P
    Chow, JHS
    Mok, TSK
    LANCET ONCOLOGY, 2001, 2 (09): : 543 - 543
  • [48] Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma
    Zheng, Hao
    Zou, Angela E.
    Saad, Maarouf A.
    Wang, Xiao Qi
    Kwok, James G.
    Korrapati, Avinaash
    Li, Pinxue
    Kisseleva, Tatiana
    Wang-Rodriguez, Jessica
    Ongkeko, Weg M.
    PLOS ONE, 2017, 12 (05):
  • [49] Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Cho, Hyo-Jung
    Cheong, Jae-Youn
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [50] Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Reply
    Wu, Chun-Ying
    Hsu, Yao-Chun
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 766 - 767
12345